Toxicology Study Guide

📖 Core Concepts Toxicology – the science of how chemicals cause harmful effects in living organisms. Dose‑Response Principle – “the dose makes the poison”; toxicity is determined by how much of a substance is taken. Key Influencing Factors – dosage, exposure duration, route (oral, inhalation, dermal), species, age, sex, health status, environment. Acute vs. Chronic Exposure – acute = single large dose; chronic = repeated low doses over time. Toxicity Metrics – $LD{50}$: dose that kills 50 % of test animals. $NOEL$: highest dose with no observable effect. $NOAEL$: highest dose with no observable adverse effect. $PEL$, $STEL$, $TWA$: workplace exposure limits (permissible, short‑term, time‑weighted). $TTC$: threshold used for very low‑level contaminants. Dose‑Response Complexities – thresholds, hormesis (beneficial low‑dose effects), chemicals with no safe level, bioaccumulation. Testing Paradigms – In vitro (cell/tissue assays, “Three Rs”), In silico (computer modeling, SAR predictions). Toxicology Disciplines – forensic, occupational, computational, environmental (including aquatic). --- 📌 Must Remember “Dose makes the poison.” No effect → low dose; toxicity → high dose. $LD{50}$ is expressed in mg kg⁻¹ (or similar) and is a median lethal dose. $NOEL$ ≠ $NOAEL$; the former ignores adverse vs any effect. PEL = 8‑hr TWA limit; STEL applies to 15–30 min spikes. Hormesis: low dose may be protective → don’t assume monotonic dose‑response. Bioaccumulative chemicals persist and concentrate up the food chain → stricter regulation. Three Rs in animal testing: Reduce, Refine, Replace. --- 🔄 Key Processes Conducting a Toxicity Study Choose route of exposure (oral, inhalation, dermal). Determine dose levels (including control, low, mid, high). Apply acute (single dose) or chronic (repeated) design. Measure endpoints → calculate $LD{50}$, $NOEL$, $NOAEL$. Risk Assessment Workflow Gather exposure data → identify route and duration. Compare exposure to regulatory limits (PEL, STEL, TWA, TTC). If exposure > limit → risk management (engineering controls, PPE). In Silico Prediction Input chemical structure → compute structure‑activity relationships (SAR). Flag potential bioaccumulative or non‑threshold chemicals. --- 🔍 Key Comparisons Acute vs. Chronic Acute: single high dose → immediate effects, $LD{50}$ relevant. Chronic: repeated low doses → cumulative effects, $NOAEL$/ $NOEL$ relevant. In Vitro vs. In Silico In Vitro: real cells/tissues, provides biological response data. In Silico: computational, fast screening, predicts SAR, no wet‑lab resources. NOEL vs. NOAEL NOEL: any measurable effect (including non‑adverse). NOAEL: only adverse effects are considered. --- ⚠️ Common Misunderstandings “If a chemical has a low $LD{50}$, it’s always dangerous.” – $LD{50}$ only reflects acute lethality; chronic low‑dose effects may be more relevant. Confusing $NOEL$ with $NOAEL$. Remember the “A” stands for adverse. Assuming hormesis is always beneficial. It occurs for specific chemicals only; cannot be generalized. Believing “in vitro = human.” Cell models lack whole‑organism metabolism; results need validation. --- 🧠 Mental Models / Intuition “Dose‑Response Curve” – visualize a hill: flat (no effect) → steep rise (toxicity). Threshold = where the hill starts; hormesis = small dip before the rise. “Three‑R Ladder” – start at Replace (no animals), then Reduce (fewer animals), finally Refine (better welfare). “Exposure Triangle” – Dose × Duration × Route = overall risk. Change any side, risk changes. --- 🚩 Exceptions & Edge Cases No‑Threshold Carcinogens – some agents (e.g., certain mutagens) are assumed to have zero safe level; regulatory limits are based on acceptable risk, not a threshold. Bioaccumulative Substances – even low environmental concentrations can become hazardous over time (e.g., PCBs). Hormetic Responses – only observed for a limited set of chemicals; do not apply the hormesis assumption universally. --- 📍 When to Use Which Use $LD{50}$ when evaluating acute lethal risk (e.g., emergency toxicology). Use $NOAEL$ for chronic risk assessments and setting acceptable daily intake values. Choose In Vitro if you need mechanistic cellular data or want to reduce animal use. Choose In Silico for early‑stage screening of large chemical libraries or when animal/cell work is impractical. Apply PEL / STEL / TWA for occupational exposure decisions; use TTC for trace contaminants in food or water. --- 👀 Patterns to Recognize Metric Clustering – acute studies → $LD{50}$; chronic studies → $NOEL$, $NOAEL$. Route‑Specific Symptoms – inhalation → respiratory effects; dermal → skin irritation; oral → gastrointestinal/hepatic. Regulatory Language – “Permissible” = OSHA, “Threshold” = TTC, “Short‑Term” = STEL. --- 🗂️ Exam Traps Distractor: “$NOEL$ is always safer than $NOAEL$.” – Wrong; $NOAEL$ is more protective because it excludes non‑adverse changes. Near‑miss: Selecting $LD{50}$ for chronic exposure questions. – $LD{50}$ only addresses acute lethality. Confusing PEL with STEL – PEL is an 8‑hr average; STEL is a short‑term spike limit. Assuming all in vitro results predict human toxicity – in vitro lacks metabolism; may miss pro‑toxic activation. ---